Talis Biomedical Corp
DelistedCIK 1584751fmd_1V7PTG8CGFF1PDD25ECEMKN47SManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2024, 18 periods
Latest annual · FY2023
Millions- Total revenues
- 2
- Gross profit
- 2
- Operating income
- (67)
- Net income
- (62)
- Free cash flow
- (54)
Latest quarter · Q2 FY2024
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (10)
- Net income
- (9)
- Free cash flow
- (11)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- n/m
Talis Biomedical Corp financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.1 million | $4.8 million | -55.7% | 10-K 2024-03-28 · proof |
| Gross profit | $2.1 million | -$3.6 million | 10-K 2024-03-28 · proof | |
| Operating income | -$66.8 million | -$115.1 million | 10-K 2024-03-28 · proof | |
| Net income | -$62 million | -$113 million | 10-K 2024-03-28 · proof | |
| Cash from operating activities | -$53.2 million | -$100.1 million | 10-K 2024-03-28 · proof | |
| Free cash flow | -$53.7 million | -$101.8 million | 10-K 2024-03-28 · proof | |
| Total assets | $94.7 million | $169.3 million | -44.1% | 10-K 2024-03-28 · proof |
| Total liabilities | $25.6 million | $42.6 million | -39.9% | 10-K 2024-03-28 · proof |
| Cash and cash equivalents | $76.7 million | $130.2 million | -41.1% | 10-K 2024-03-28 · proof |
- What was Talis Biomedical Corp's revenue in fiscal 2023?
- Talis Biomedical Corp reported revenue of $2.1 million for fiscal 2023 (the year ended Dec 31, 2023), against $4.8 million the year before (-55.7%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was Talis Biomedical Corp's gross profit in fiscal 2023?
- Talis Biomedical Corp reported gross profit of $2.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$3.6 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was Talis Biomedical Corp's operating income in fiscal 2023?
- Talis Biomedical Corp reported operating income of -$66.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$115.1 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was Talis Biomedical Corp's net income in fiscal 2023?
- Talis Biomedical Corp reported net income of -$62 million for fiscal 2023 (the year ended Dec 31, 2023), against -$113 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was Talis Biomedical Corp's cash from operating activities in fiscal 2023?
- Talis Biomedical Corp reported cash from operating activities of -$53.2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$100.1 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was Talis Biomedical Corp's free cash flow in fiscal 2023?
- Talis Biomedical Corp reported free cash flow of -$53.7 million for fiscal 2023 (the year ended Dec 31, 2023), against -$101.8 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What are Talis Biomedical Corp's total assets?
- As of Dec 31, 2023, Talis Biomedical Corp reported total assets of $94.7 million, against $169.3 million a year earlier (-44.1%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What are Talis Biomedical Corp's total liabilities?
- As of Dec 31, 2023, Talis Biomedical Corp reported total liabilities of $25.6 million, against $42.6 million a year earlier (-39.9%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What are Talis Biomedical Corp's cash and cash equivalents?
- As of Dec 31, 2023, Talis Biomedical Corp reported cash and cash equivalents of $76.7 million, against $130.2 million a year earlier (-41.1%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1584751&period_type=annual&limit=5"Information only, not investment advice.